Qingsong Lin Selected Research

artemisinin (artemisinine)

1/2022	Selective Inhibition of Plasmodium falciparum ATPase 6 by Artemisinins and Identification of New Classes of Inhibitors after Expression in Yeast.
11/2017	Artemisinin as an anticancer drug: Recent advances in target profiling and mechanisms of action.
7/2017	Mechanistic Investigation of the Specific Anticancer Property of Artemisinin and Its Combination with Aminolevulinic Acid for Enhanced Anticolorectal Cancer Activity.
10/2016	Mechanism-Guided Design and Synthesis of a Mitochondria-Targeting Artemisinin Analogue with Enhanced Anticancer Activity.
4/2016	Chemical proteomics approach reveals the direct targets and the heme-dependent activation mechanism of artemisinin in Plasmodium falciparum using an artemisinin-based activity probe.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Qingsong Lin Research Topics

Disease

23	Neoplasms (Cancer) 07/2022 - 07/2007
8	Infections 12/2020 - 09/2007
8	Colorectal Neoplasms (Colorectal Cancer) 08/2017 - 06/2006
6	Neoplasm Metastasis (Metastasis) 01/2018 - 06/2008
4	Colonic Neoplasms (Colon Cancer) 07/2022 - 06/2008
4	Starvation 01/2022 - 05/2014
3	Malaria 01/2022 - 04/2016
3	Inflammation (Inflammations) 01/2022 - 03/2014
3	Virus Diseases (Viral Diseases) 01/2021 - 11/2008
3	Leukemia 12/2020 - 03/2016
3	Melanoma (Melanoma, Malignant) 01/2018 - 05/2015
3	Mitochondrial Diseases (Mitochondrial Disease) 08/2017 - 03/2010
3	Hepatocellular Carcinoma (Hepatoma) 01/2016 - 12/2008
2	Sepsis (Septicemia) 03/2022 - 12/2020
2	Gingivitis 01/2022 - 12/2021
2	Breast Neoplasms (Breast Cancer) 01/2017 - 12/2007
2	Carcinogenesis 12/2008 - 06/2006
1	Hematologic Diseases (Blood Diseases) 03/2022
1	Bacteremia 03/2022
1	Gout 01/2021
1	Acquired Immunodeficiency Syndrome (AIDS) 11/2020
1	Dengue (Dengue Fever) 02/2020
1	Leptospirosis 02/2020
1	Tuberculosis (Tuberculoses) 01/2020
1	Genomic Instability 01/2018
1	Cardiomyopathies (Cardiomyopathy) 01/2017
1	Ewing Sarcoma (Sarcoma, Ewing) 01/2016
1	Cholangiocarcinoma 01/2016
1	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 01/2016
1	Ovarian Neoplasms (Ovarian Cancer) 01/2016
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2016
1	Glioma (Gliomas) 01/2016
1	Embryonal Rhabdomyosarcoma 01/2016

Drug/Important Bio-Agent (IBA)

31	Proteins (Proteins, Gene)FDA Link 07/2022 - 06/2006
9	ProteomeIBA 01/2022 - 06/2008
5	artemisinin (artemisinine)IBA 01/2022 - 04/2016
5	Biological ProductsIBA 01/2021 - 03/2014
3	Biomarkers (Surrogate Marker)IBA 07/2013 - 09/2010
3	Butyrates (Butyrate)IBA 12/2012 - 06/2008
2	Fatty Acids (Saturated Fatty Acids)IBA 01/2022 - 08/2017
2	DNA (Deoxyribonucleic Acid)IBA 11/2021 - 01/2016
2	Fumarate Hydratase (Fumarase)IBA 11/2021 - 11/2020
2	CurcuminIBA 01/2021 - 02/2016
2	Anti-Bacterial Agents (Antibiotics)IBA 12/2020 - 02/2020
2	Pharmaceutical PreparationsIBA 01/2020 - 10/2011
2	CarbonIBA 01/2019 - 01/2019
2	Amino Acids FDA Link 01/2019 - 10/2016
2	andrographolideIBA 08/2017 - 03/2014
2	Heme (Haem)IBA 07/2017 - 10/2016
2	Sirolimus (Rapamycin)FDA Link 10/2016 - 05/2014
2	Carrier Proteins (Binding Protein)IBA 07/2013 - 12/2008
2	IsotopesIBA 01/2011 - 04/2007
2	Tyrosine (L-Tyrosine)FDA Link 12/2007 - 07/2007
1	celastrolIBA 07/2022
1	Salivary Proteins and PeptidesIBA 01/2022
1	Gonadal Steroid Hormones (Sex Hormones)IBA 01/2022
1	Fatty Acid Synthases (Fatty Acid Synthase)IBA 01/2022
1	Ligases (Synthetase)IBA 01/2022
1	Transfer RNA (tRNA)IBA 01/2022
1	SaponinsIBA 01/2022
1	Glutamate-Ammonia Ligase (Glutamine Synthetase)IBA 01/2022
1	Ribosomal Proteins (Ribosomal Protein)IBA 01/2022
1	Glycogen Phosphorylase (Phosphorylase, Glycogen)IBA 01/2022
1	Glycoproteins (Glycoprotein)IBA 01/2022
1	Salivary CystatinsIBA 12/2021
1	Cystatin CIBA 12/2021
1	EnzymesIBA 11/2021
1	BenzbromaroneIBA 01/2021
1	Uricosuric AgentsIBA 01/2021
1	Alkynes (Acetylenes)IBA 01/2021
1	Cytochrome P-450 CYP3AIBA 01/2021
1	QuinolonesIBA 12/2020
1	Tazobactam Drug Combination Piperacillin (Zosyn)FDA LinkGeneric 12/2020
1	Leucine (L-Leucine)FDA Link 02/2020
1	lipopolysaccharide-binding proteinIBA 02/2020
1	Blood Proteins (Serum Proteins)IBA 02/2020
1	LipopolysaccharidesIBA 02/2020
1	Pyrazinamide FDA LinkGeneric 01/2020
1	Thioredoxin hIBA 01/2019
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2019
1	Proline (L-Proline)FDA Link 01/2018
1	Histone Deacetylase InhibitorsIBA 01/2018
1	ResveratrolIBA 01/2018
1	Vorinostat FDA Link 01/2018
1	Mechanistic Target of Rapamycin Complex 1IBA 01/2018
1	Antimalarials (Antimalarial Agents)IBA 11/2017
1	ArtemisininsIBA 11/2017
1	ArtesunateIBA 08/2017
1	Aminolevulinic Acid (Levulan)FDA Link 07/2017
1	TeaIBA 01/2017
1	epigallocatechin gallate (epigallocatechin-3-gallate)IBA 01/2017
1	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 10/2016
1	synaptojaninIBA 03/2016
1	Phosphoinositide PhosphatasesIBA 03/2016
1	Eukaryotic Initiation Factor-2 (EIF 2)IBA 02/2016
1	70-kDa Ribosomal Protein S6 Kinases (Ribosomal Protein S6 Kinases, 70 kDa)IBA 02/2016
1	RNA (Ribonucleic Acid)IBA 01/2016
1	Messenger RNA (mRNA)IBA 01/2016
1	panduratin AIBA 05/2015

Therapy/Procedure

8	Therapeutics 03/2022 - 07/2007